AbbVie
ABBV
#26
Rank
โ‚น35.622 T
Marketcap
โ‚น20,155
Share price
-0.29%
Change (1 day)
40.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น335.38 Billion a decrease over its 2023 earnings that were of โ‚น564.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-57.08%
2024 โ‚น335.38 B-40.54%
2023 โ‚น564.08 B-53.62%
2022 โ‚น1.216 T3.76%
2021 โ‚น1.172 T282.25%
2020 โ‚น306.67 B-59.67%
2019 โ‚น760.47 B62.13%
2018 โ‚น469.04 B-32.74%
2017 โ‚น697.38 B-1.99%
2016 โ‚น711.55 B18.65%
2015 โ‚น599.73 B180.5%
2014 โ‚น213.80 B-55.57%
2013 โ‚น481.22 B-6.86%
2012 โ‚น516.69 B56.05%
2011 โ‚น331.09 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.069 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น725.00 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.031 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น744.04 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น892.24 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.84 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น841.41 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น1.181 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น52.63 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA